Life Sciences Veteran Michael Davies Ph.D. Joins TraceLink to Lead Global Sales Growth
Wakefield, MA (PRWEB) January 23, 2014 -- TraceLink Inc., the leader in global pharmaceutical serialization, drug track and trace compliance and supply network performance solutions, announced today that life sciences industry veteran Michael Davies Ph.D. has joined the company as the Senior Vice President of Global Sales and Business Development.
Mike joins the TraceLink leadership team and will be responsible for shaping the company’s worldwide sales strategy and driving overall revenue generation. In addition, he is charged with building new business and channel partnerships to expand global market access for TraceLink’s cloud-based software application platform providing solutions for companies across the global life sciences supply chain.
“We are excited to have Mike join TraceLink and lead our global expansion in the life sciences supply chain,” said Shabbir Dahod, President and CEO of TraceLink. “His sales leadership, global experience and deep knowledge of the unique needs of the pharmaceutical industry further enhance the strong team we have built creating solutions that help the industry meet global regulatory compliance requirements and improve performance across the supply chain from ingredient to patient.”
“A major factor in my decision to join TraceLink is the company’s passion for tackling some of the biggest challenges facing the global pharmaceutical industry today: protecting patient safety, ensuring global track and trace compliance and improving access to global markets for needed medicines,” said Mike Davies, Senior Vice President of Global Sales and Business Development at TraceLink. “I am thrilled to have the opportunity to join a team so dedicated to this mission and I look forward to helping TraceLink grow its global business and build long-term customer relationships.”
With an eighteen year career in the biopharmaceutical industry, Mike has a proven track record of building and scaling sales organizations, developing markets and helping customers succeed at companies such as Oracle, Phase Forward and Parke-Davis (now Pfizer). As Vice President for Global Sales in the Health Sciences Global Business Unit at Oracle Corporation, he helped shape business unit strategy and led sales execution for Oracle’s Life Sciences and Healthcare solutions. At Phase Forward, Mike was instrumental in helping the company rapidly grow revenues by leading sales teams and designing and implementing channel partner programs for the company’s electronic data management and pharmacovigilance solutions. Mike started his career in various Life Sciences roles at Parke-Davis and Pfizer and he holds a Bachelor of Science degree from the University of Sunderland and a Ph.D. in Physiology & Pharmacology from the University of Bradford.
TraceLink serves the global life science industry through the TraceLink Life Sciences Cloud network platform, pharmaceutical track and trace solutions and supply network performance applications that help pharmaceutical companies and supply network partners connect, share key business data and collaborate across supply, production and distribution operations. Market leaders, including four of the top-10 pharmaceutical companies, use a single integrated connection to the TraceLink Life Sciences Cloud for:
• Compliance with pharmaceutical serialization, product tracing and government reporting regulations for the US H.R. 3204 Drug Quality and Security Act, China, Brazil, Korea and other global drug track and trace regulations
• Creation of a supply chain control tower that improves speed across external supply activities, increases visibility and control across the outsourced production lifecycle and enhances agility in meeting patient demand across global markets
To learn more about TraceLink's scalable solutions serving pharmaceutical companies, CMO/CPOs, wholesale distributors and pharmacies of all sizes, complexities and locations across the globe, visit us at http://www.tracelink.com.
About TraceLink
TraceLink protects patients, enables health, grows profits and ensures compliance for companies across the global Life Sciences network through the TraceLink Life Sciences Cloud. The TraceLink Life Sciences Cloud is an Amazon AWS-based cloud application platform which enables complete global connectivity, visibility and traceability of pharmaceuticals from raw materials to patient. A single point and click connection to the Life Sciences Cloud delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. Winner of numerous industry awards including the Amazon AWS Global Start-Up Challenge Grand Prize and the Edison Award for Innovation in Health Management, the TraceLink Life Sciences Cloud is relied upon by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit http://www.tracelink.com or follow us on LinkedIn.
TraceLink is funded by FirstMark Capital. FirstMark Capital is an early stage venture capital firm based in New York City. Our mission is to partner with exceptional entrepreneurs who are changing the world by solving meaningful problems. We have built a deeply engaged community among the extraordinary teams in our network to spread ideas and opportunities. We are privileged to work alongside the founders of remarkable businesses like Pinterest, Lumosity, Aereo, TapAd, Shopify, Riot Games, and dozens more. Visit us in New York City or online at firstmarkcap.com and @FirstMarkCap.
Brian Daleiden, TraceLink Inc., http://www.tracelink.com, +1 (615) 516-6315, [email protected]
Share this article